ARS Investor Fights To Keep Citigroup In Court
Braintree Laboratories Inc. has appealed a federal court's decision to order arbitration in its lawsuit accusing Citigroup Inc.'s brokerage division of pushing the specialty pharmaceutical company to buy more than $41...To view the full article, register now.
Already a subscriber? Click here to view full article